These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


450 related items for PubMed ID: 2047887

  • 1. Relationship of inflammatory bowel disease and primary sclerosing cholangitis.
    Fausa O, Schrumpf E, Elgjo K.
    Semin Liver Dis; 1991 Feb; 11(1):31-9. PubMed ID: 2047887
    [Abstract] [Full Text] [Related]

  • 2. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
    Bayraktar Y, Arslan S, Saglam F, Uzunalimoglu B, Kayhan B.
    Hepatogastroenterology; 1998 Feb; 45(24):2064-72. PubMed ID: 9951867
    [Abstract] [Full Text] [Related]

  • 3. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer.
    Broomé U, Bergquist A.
    Semin Liver Dis; 2006 Feb; 26(1):31-41. PubMed ID: 16496231
    [Abstract] [Full Text] [Related]

  • 4. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH.
    Scand J Gastroenterol; 2009 Feb; 44(1):46-55. PubMed ID: 18609187
    [Abstract] [Full Text] [Related]

  • 5. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.
    Karlsen TH, Hampe J, Wiencke K, Schrumpf E, Thorsby E, Lie BA, Broomé U, Schreiber S, Boberg KM.
    Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974
    [Abstract] [Full Text] [Related]

  • 6. Hepatobiliary disease in inflammatory bowel disease.
    Balan V, LaRusso NF.
    Gastroenterol Clin North Am; 1995 Sep; 24(3):647-69. PubMed ID: 8809241
    [Abstract] [Full Text] [Related]

  • 7. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A, Gunson BK, Ussatoff V, Nightingale P, Candinas D, Radley S, Mayer A, Buckels JA, McMaster P, Neuberger J, Mirza DF.
    Transplantation; 2003 Jun 27; 75(12):1983-8. PubMed ID: 12829898
    [Abstract] [Full Text] [Related]

  • 8. Fatigue in patients with primary sclerosing cholangitis.
    Björnsson E, Simren M, Olsson R, Chapman RW.
    Scand J Gastroenterol; 2004 Oct 27; 39(10):961-8. PubMed ID: 15513335
    [Abstract] [Full Text] [Related]

  • 9. Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis.
    Bergquist A, Montgomery SM, Bahmanyar S, Olsson R, Danielsson A, Lindgren S, Prytz H, Hultcrantz R, Lööf LA, Sandberg-Gertzén H, Almer S, Askling J, Ehlin A, Ekbom A.
    Clin Gastroenterol Hepatol; 2008 Aug 27; 6(8):939-43. PubMed ID: 18674735
    [Abstract] [Full Text] [Related]

  • 10. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
    Bergquist A, Glaumann H, Persson B, Broomé U.
    Hepatology; 1998 Feb 27; 27(2):311-6. PubMed ID: 9462625
    [Abstract] [Full Text] [Related]

  • 11. [Primary sclerosing cholangitis and inflammatory bowel disease].
    Schrumpf E, Fausa O, Aadland E, Elgjo K, Kolmannskog F.
    Tidsskr Nor Laegeforen; 1990 Apr 10; 110(10):1212-6. PubMed ID: 1970674
    [Abstract] [Full Text] [Related]

  • 12. Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis.
    Saarinen S, Olerup O, Broomé U.
    Am J Gastroenterol; 2000 Nov 10; 95(11):3195-9. PubMed ID: 11095341
    [Abstract] [Full Text] [Related]

  • 13. Hepatobiliary associations with inflammatory bowel disease.
    Knight C, Murray KF.
    Expert Rev Gastroenterol Hepatol; 2009 Dec 10; 3(6):681-91. PubMed ID: 19929587
    [Abstract] [Full Text] [Related]

  • 14. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study.
    Gorgun E, Remzi FH, Manilich E, Preen M, Shen B, Fazio VW.
    Surgery; 2005 Oct 10; 138(4):631-7; discussion 637-9. PubMed ID: 16269291
    [Abstract] [Full Text] [Related]

  • 15. Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease.
    O'Toole A, Alakkari A, Keegan D, Doherty G, Mulcahy H, O'Donoghue D.
    Clin Gastroenterol Hepatol; 2012 Apr 10; 10(4):439-41. PubMed ID: 22094024
    [Abstract] [Full Text] [Related]

  • 16. Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis.
    Tischendorf JJ, Meier PN, Strassburg CP, Klempnauer J, Hecker H, Manns MP, Krüger M.
    Scand J Gastroenterol; 2006 Oct 10; 41(10):1227-34. PubMed ID: 16990210
    [Abstract] [Full Text] [Related]

  • 17. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Torres J, Pineton de Chambrun G, Itzkowitz S, Sachar DB, Colombel JF.
    Aliment Pharmacol Ther; 2011 Sep 10; 34(5):497-508. PubMed ID: 21692821
    [Abstract] [Full Text] [Related]

  • 18. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN, Blanchard JF, Rawsthorne P, Yu N.
    Am J Gastroenterol; 2001 Apr 10; 96(4):1116-22. PubMed ID: 11316157
    [Abstract] [Full Text] [Related]

  • 19. PSC, AIH and overlap syndrome in inflammatory bowel disease.
    Trivedi PJ, Chapman RW.
    Clin Res Hepatol Gastroenterol; 2012 Oct 10; 36(5):420-36. PubMed ID: 22306055
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.